CRISPR

CRISPR: The Software Update for Human DNA

I am so ancient I don’t even buy green bananas anymore, but there is a breakthrough on the horizon that gives me—and the rest of the world—tremendous hope. It’s called CRISPR.

You may not have heard of it yet (pronounced ‘crisper’), but it stands for Clusters of Regularly Interspaced Short Palindromic Repeats. Essentially, it is a tool that allows scientists to edit genes in plants, animals, and humans with unprecedented speed and low cost. Think of CRISPR as software programming for DNA.

How It Works: Somatic vs. Germline

There are two primary ways gene therapy is applied:

• Germline Editing: This changes the DNA in reproductive cells (sperm and eggs). These changes are permanent and passed down to future generations.

• Somatic Therapy: This targets non-reproductive cells and affects only the recipient.

To answer a question I’ve been investigating: How does the change reach the whole body? In somatic therapy, scientists don’t usually edit every cell at once. Instead, they target the “source.” For blood diseases, they edit the stem cells in the bone marrow. Once those “factory” cells are corrected, every new blood cell they produce carries the repair. It’s not about changing every cell individually; it’s about fixing the blueprint at the assembly line.

Shutterstock

Real-World Success Stories

We are no longer talking about science fiction; CRISPR is already saving lives.

• Sickle Cell Anemia: This painful disorder damages organs and can be fatal. In 2020, a patient treated with CRISPR reported that virtually all complications of her disorder vanished.

• Thalassemia: This condition causes bone deformities and requires constant blood transfusions. Following CRISPR treatment, one patient was able to stop transfusions entirely within five months.

• Heart Disease: A company called Verve used “base editing” to knock out genes in monkeys associated with “bad” (LDL) cholesterol. The result? LDL levels plummeted by 60% with no serious side effects. Since humans share these same genes, this could eventually replace a lifetime of daily statins.

The Numbers Behind the Need

There are more than 6,000 diseases caused by genetic mutations, and 95% of them currently have no approved treatment.

• Over 5 million babies are born globally each year with genetic diseases or major birth defects.

• Genetic conditions account for 20% of infant deaths.

• Roughly 10% of adults and 30% of children in hospitals are there due to genetically related problems.

CRISPR has the potential to solve these problems permanently.

The Final Frontier: Mitochondria

The latest breakthrough involves CRISPR-CasΦ, a tiny enzyme small enough to enter the mitochondria.

Mitochondria are the “power plants” of our cells, turning oxygen and nutrients into energy. When they fail, the results are catastrophic: heart failure, dementia, or seizures. Until now, our editing tools were too bulky to get inside these power plants. The team at the Broad Institute of MIT and Harvard has finally developed a “mitochondrial base editor,” opening the door to curing diseases we once thought were unreachable.

The Future

Whether it’s eradicating malaria by editing mosquitoes or repairing the human heart, CRISPR is moving at warp speed. I will continue to release new updates on this technology as it develops.